Detalles de la búsqueda
1.
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease.
J Neurochem
; 134(4): 740-7, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25962878
2.
Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats.
Clin Exp Pharmacol Physiol
; 42(6): 695-703, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25904005
3.
Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
Front Neurol
; 10: 232, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941089
4.
Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer.
Front Cell Neurosci
; 11: 184, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28701927
5.
Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease.
Front Neurosci
; 11: 306, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28620274
6.
Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
Stem Cells Transl Med
; 4(9): 1073-85, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26198165
7.
Single or combined treatment with L-DOPA and quinpirole differentially modulate expression and phosphorylation of key regulatory kinases in neuroblastoma cells.
Neurosci Lett
; 552: 168-73, 2013 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-23896526
Resultados
1 -
7
de 7
1
Próxima >
>>